Researchers present in-depth review of 145 clinical trials for Parkinson’s

News

Author: Sophie BatesPublished: 27 August 2020

Prep: Cook: Serves:

A recent report conducted by researchers at The Cure Parkinson’s Trust and research advocates, presents an in-depth review of current clinical trials that are targeting Parkinson’s.

With the global number of people living with Parkinson’s expected to double by 2040, the objective of the investigation was to increase awareness of clinical trials and create opportunities for collaboration between the research community and people with the condition.

As part of the review – published in the Journal of Parkinson’s Disease – researchers categorised 145 trials into the type of drug being tested and the stage of their clinical development, to highlight trends in how the condition is being targeted.

Parkinson’s research advocate Dr Kevin McFarthing, said: “The number of clinical trials under way is encouraging for Parkinson’s community, especially the high proportion of repurposed initiatives that increase the chances of a new therapy becoming available quickly.”

To read more on this topic click here.

For more information on the latest Parkinson’s research please visit the Parkinson’s Europe website.

New machine learning model could help pinpoint stages of Parkinson’s

Last Month

Next Month

Go Back

Share this story

Comments

Perspectives

Arise, Sir Billy Connolly

Billy Connolly receives a knighthood

Our 5 favourite videos from the WPC 2019 competition

We look at some of this year’s video submissions

All hands on deck: rowing 3,200 miles for Parkinson’s disease

Billy Taylor on raising awareness at sea

Could a sea sponge support the search for Parkinson’s disease treatments?

How could a molecule in a sea sponge help treat Parkinson’s and similar conditions? Researchers at the University of California, Los Angeles (UCLA), in the US, recently explored this question. Their findings were published in the journal ‘Science’. The team examined a molecule known as lissodendoric acid A, which appears to counteract other molecules that damage DNA, proteins and whole cells – and was recently discovered in a sea sponge. The research team used an oft-neglected compound called a cyclic allene to control a step in the chain of chemical reactions, which enabled them to create a version of the molecule in a lab. Scientists believe that the ability to synthetically produce lissodendoric acid A will help them assess whether it can inform future therapies for conditions like Parkinson’s. UCLA’s Professor Neil Garg, the corresponding author of the study, said: “We hope others will also be able to use cyclic…

Study finds just six minutes of daily exercise might delay onset of Parkinson’s disease

Regular exercise is a common therapeutic strategy for people with Parkinson’s. Now, a study from New Zealand has suggested that daily physical activity might even delay the onset of this condition. Published in ‘The Physiological Society’, the study focused on a protein called brain-derived neurotrophic factor (BDNF) – which has previously been shown to boost cognitive performance. The researchers assessed the impact of fasting and physical activity on BDNF production in 12 people aged 18 to 56. The tests involved fasting and completing exercises of varying intensity, such as cycling for six minutes, as well as combinations of both fasting and physical activity. The results showed that brief, intense exercise was the best option for increasing the production of BDNF – with the protein increasing by a factor of four to five times compared to light exercise or fasting. Because BDNF can protect the brain from cognitive decline, the findings could…

Machine learning may help predict risk of freezing of gait in Parkinson’s disease

Difficulty taking steps forward, often referred to as the freezing of gait (FOG), is a common symptom experienced by people with Parkinson’s and one that can be difficult to predict. China-based researchers suggest that machine learning – artificial intelligence (AI) that uses algorithms to analyse data – could help predict the risk of freezing of gait developing in the early stages of the condition. Their study, published in ‘npj Parkinson’s Disease’, gave laboratory and clinical data to a machine learning model brain. This information was collected from 158 adults with untreated early-stage Parkinson’s and 73 healthy adults over a five-year period. They found that the risk of FOG could be predicted with an accuracy rate of up to 78%. The study authors suggested that machine learning methods “have the potential to help predict future FOG in patients with early Parkinson’s at an individual level”.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

Researchers present in-depth review of 145 clinical trials for Parkinson’s

News

Author: Sophie BatesPublished: 27 August 2020

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Perspectives

Arise, Sir Billy Connolly

Global update

Our 5 favourite videos from the WPC 2019 competition

Interviews

All hands on deck: rowing 3,200 miles for Parkinson’s disease

Could a sea sponge support the search for Parkinson’s disease treatments?

Study finds just six minutes of daily exercise might delay onset of Parkinson’s disease

Machine learning may help predict risk of freezing of gait in Parkinson’s disease

{title}

Subscribe

Researchers present in-depth review of 145 clinical trials for Parkinson’s

News

Author: Sophie BatesPublished: 27 August 2020

Last Month

Next Month

Share this story

Comments

Related articles

Perspectives

Arise, Sir Billy Connolly

Global update

Our 5 favourite videos from the WPC 2019 competition

Interviews

All hands on deck: rowing 3,200 miles for Parkinson’s disease

Could a sea sponge support the search for Parkinson’s disease treatments?

Study finds just six minutes of daily exercise might delay onset of Parkinson’s disease

Machine learning may help predict risk of freezing of gait in Parkinson’s disease

{title}

Subscribe

Sign in